Two Sigma Investments, LP Edwards Lifesciences Corp Call Options Transaction History

Two Sigma Investments, LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $31,911 - $39,204	-300 Reduced 6.0%	4,700 $609,000
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $33,536 - $41,904	-400 Reduced 7.41%	5,000 $518,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $21,507 - $27,369	300 Added 5.88%	5,400 $493,000
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $178,374 - $238,545	-3,100 Reduced 37.8%	5,100 $352,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $322,650 - $369,405	4,500 Added 121.62%	8,200 $1.91 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $104,635 - $128,231	1,700 Added 85.0%	3,700 $814,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $111,480 - $128,820	2,000 New	2,000 $369,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $530,120 - $673,148	-11,600 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $492,420 - $595,080	11,600 New	11,600 $1.69 Million

1,417

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.